[Systemic enzyme therapy in the treatment of children with lower orbital wall fractures]

Area of Science:

• Ophthalmology
• Traumatology
• Pharmacology

Background:

• Orbital wall fractures can lead to complications like muscle strangulation and hernias.
• Early intervention is crucial for optimal healing and minimizing scar tissue formation.
• Systemic enzyme therapy offers a potential non-surgical approach to managing these injuries.

Purpose of the Study:

• To evaluate the efficacy of Wobenzim, a systemic enzyme therapy, in treating lower orbital wall fractures in children.
• To assess the impact of Wobenzim on healing conditions and scar tissue formation.
• To compare the outcomes of Wobenzim monotherapy with conventional therapy.

Main Methods:

• A study involving 26 children with lower orbital wall fractures treated with Wobenzim monotherapy within 7 days of injury.
• A control group of 24 patients received standard systemic dehydration and vessel-strengthening therapy.
• Outcomes measured included inflammatory manifestation duration, complication rates, and need for surgical intervention.

Main Results:

• Wobenzim therapy significantly reduced the time for inflammatory manifestations to subside.
• The treatment prevented complications such as inferior rectus muscle strangulation and orbital soft tissue hernias.
• Fewer patients in the Wobenzim group required surgical plastic repair of the orbital wall compared to the control group.

Conclusions:

• Systemic enzyme therapy with Wobenzim is effective in managing pediatric orbital wall fractures.
• Wobenzim improves healing, reduces inflammation, and prevents serious complications.
• This therapy offers a viable alternative to surgery in a substantial number of cases.